Stocks & Investing
Stocks and Investing
Stocks and Investing
Tue, March 8, 2022
[ Tue, Mar 08th 2022
] - WOPRAI
[ Tue, Mar 08th 2022
] - WOPRAI
[ Tue, Mar 08th 2022
] - WOPRAI
Mon, March 7, 2022
[ Mon, Mar 07th 2022
] - WOPRAI
[ Mon, Mar 07th 2022
] - WOPRAI
[ Mon, Mar 07th 2022
] - WOPRAI
[ Mon, Mar 07th 2022
] - WOPRAI
[ Mon, Mar 07th 2022
] - WOPRAI
[ Mon, Mar 07th 2022
] - WOPRAI
[ Mon, Mar 07th 2022
] - WOPRAI
[ Mon, Mar 07th 2022
] - WOPRAI
[ Mon, Mar 07th 2022
] - WOPRAI
[ Mon, Mar 07th 2022
] - WOPRAI
[ Mon, Mar 07th 2022
] - WOPRAI
[ Mon, Mar 07th 2022
] - WOPRAI
[ Mon, Mar 07th 2022
] - WOPRAI
[ Mon, Mar 07th 2022
] - WOPRAI
[ Mon, Mar 07th 2022
] - WOPRAI
[ Mon, Mar 07th 2022
] - WOPRAI
[ Mon, Mar 07th 2022
] - WOPRAI
[ Mon, Mar 07th 2022
] - WOPRAI
[ Mon, Mar 07th 2022
] - WOPRAI
[ Mon, Mar 07th 2022
] - WOPRAI
[ Mon, Mar 07th 2022
] - WOPRAI
[ Mon, Mar 07th 2022
] - WOPRAI
[ Mon, Mar 07th 2022
] - WOPRAI
[ Mon, Mar 07th 2022
] - WOPRAI
Salveen Richter Maintained (ALLO) at Hold with Decreased Target to $12 on, Mar 7th, 2022
Salveen Richter of Goldman Sachs, Maintained "Allogene Therapeutics, Inc." (ALLO) at Hold with Decreased Target from $20 to $12 on, Mar 7th, 2022.
Salveen has made no other calls on ALLO in the last 4 months.
There is 1 other peer that has a rating on ALLO. Out of the 1 peers that are also analyzing ALLO, 0 agree with Salveen's Rating of Hold.
This is the rating of the analyst that currently disagrees with Salveen
- Luca Issi of "RBC Capital" Maintained at Buy with Decreased Target to $35 on, Tuesday, December 14th, 2021
